{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:40:09Z","timestamp":1793418009216,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-04038-3","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:04:20Z","timestamp":1768608260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Postoperative seizure, stroke, hemorrhage, and cerebral hyperperfusion syndrome rates in adult patients with moyamoya disease undergoing revascularization: a systematic review and proportional meta-analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Sara","family":"Luck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Nilchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Garton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir R.","family":"Dehdashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Stieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"10","key":"4038_CR1","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","volume":"54","author":"NR Gonzalez","year":"2023","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY et al (2023) Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association\/American Stroke Association. Stroke 54(10):e465\u2013e479. https:\/\/doi.org\/10.1161\/STR.0000000000000443","journal-title":"Stroke"},{"issue":"2","key":"4038_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","volume":"21","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S (2016) A new horizon of Moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med 21(2):55\u201370. https:\/\/doi.org\/10.1007\/s12199-015-0498-7","journal-title":"Environ Health Prev Med"},{"issue":"16","key":"4038_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167864","volume":"26","author":"E Bagyinszky","year":"2025","unstructured":"Bagyinszky E, Yang Y, An SSA (2025) Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies. Int J Mol Sci 26(16):7864. https:\/\/doi.org\/10.3390\/ijms26167864","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4038_CR4","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, Niu X, Liang F et al (2023) RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain 146(11):4674\u20134689. https:\/\/doi.org\/10.1093\/brain\/awad225","journal-title":"Brain"},{"issue":"8","key":"4038_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of Moyamoya disease. J Neurol Neurosurg Psychiatry 79(8):900\u2013904. https:\/\/doi.org\/10.1136\/jnnp.2007.130666","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4038_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER (2009) Moyamoya disease and Moyamoya syndrome. N Engl J Med 360(12):1226\u20131237. https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"4038_CR7","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/j.wneu.2023.11.075","volume":"182","author":"C Huang","year":"2024","unstructured":"Huang C, Huang C, Zhan X (2024) Predictive factors for seizures after revascularization in patients with Moyamoya disease. World Neurosurg 182:e205\u2013e209. https:\/\/doi.org\/10.1016\/j.wneu.2023.11.075","journal-title":"World Neurosurg"},{"issue":"3","key":"4038_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular Moyamoya disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288\u2013299. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"issue":"8","key":"4038_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y et al (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol 21(8):747\u2013758. https:\/\/doi.org\/10.1016\/S1474-4422(22)00165-X","journal-title":"Lancet Neurol"},{"issue":"2","key":"4038_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00701-012-1545-4","volume":"155","author":"BA Gross","year":"2013","unstructured":"Gross BA, Du R (2013) Adult Moyamoya after revascularization. Acta Neurochir (Wien) 155(2):247\u2013254. https:\/\/doi.org\/10.1007\/s00701-012-1545-4","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","volume":"128","author":"JP Jeon","year":"2017","unstructured":"Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW (2017) Meta-analysis of the surgical outcomes of symptomatic Moyamoya disease in adults. J Neurosurg 128(3):793\u2013799. https:\/\/doi.org\/10.3171\/2016.11.JNS161688","journal-title":"J Neurosurg"},{"issue":"1","key":"4038_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.236.45","volume":"236","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Tominaga T (2015) Current status of revascularization surgery for Moyamoya disease: special consideration for its \u2018Internal carotid-External carotid (IC-EC) conversion\u2019 as the physiological reorganization system. Tohoku J Exp Med 236(1):45\u201353. https:\/\/doi.org\/10.1620\/tjem.236.45","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"4038_CR13","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3171\/2017.2.JNS162405","volume":"128","author":"X Deng","year":"2017","unstructured":"Deng X, Gao F, Zhang D et al (2017) Direct versus indirect bypasses for adult ischemic-type Moyamoya disease: a propensity score\u2013matched analysis. J Neurosurg 128(6):1785\u20131791. https:\/\/doi.org\/10.3171\/2017.2.JNS162405","journal-title":"J Neurosurg"},{"key":"4038_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76559-8","volume":"14","author":"JH Kim","year":"2024","unstructured":"Kim JH, Hong N, Kim H et al (2024) Autoregulatory dysfunction in adult Moyamoya disease with cerebral hyperperfusion syndrome after bypass surgery. Sci Rep 14:26451. https:\/\/doi.org\/10.1038\/s41598-024-76559-8","journal-title":"Sci Rep"},{"issue":"5","key":"4038_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.wneu.2011.10.041","volume":"78","author":"K Hayashi","year":"2012","unstructured":"Hayashi K, Horie N, Suyama K, Nagata I (2012) Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction. World Neurosurg 78(5):447\u2013454. https:\/\/doi.org\/10.1016\/j.wneu.2011.10.041","journal-title":"World Neurosurg"},{"issue":"5","key":"4038_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3171\/2009.3.JNS08837","volume":"111","author":"RM Starke","year":"2009","unstructured":"Starke RM, Komotar RJ, Hickman ZL et al (2009) Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease: clinical article. J Neurosurg 111(5):936\u2013942. https:\/\/doi.org\/10.3171\/2009.3.JNS08837","journal-title":"J Neurosurg"},{"key":"4038_CR17","unstructured":"PROSPERO"},{"key":"4038_CR18","unstructured":"Cochrane Library About PICO | Cochrane Library. Accessed October 9 (2024) https:\/\/www.cochranelibrary.com\/about-pico"},{"key":"4038_CR19","doi-asserted-by":"publisher","unstructured":"Munn Z, Barker TH, Moola S et al Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database Syst Rev Implement Rep. 2019;Publish Ahead of Print. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"4038_CR20","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses | Cochrane. Accessed July 23 (2025) https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-10#section-10-10"},{"key":"4038_CR21","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/j.wneu.2018.06.218","volume":"118","author":"S Nomura","year":"2018","unstructured":"Nomura S, Yamaguchi K, Ishikawa T, Kawashima A, Okada Y, Kawamata T (2018) Factors of delayed hyperperfusion and the importance of repeated cerebral blood flow evaluation for hyperperfusion after direct bypass for Moyamoya disease. World Neurosurg 118:e468\u2013e472. https:\/\/doi.org\/10.1016\/j.wneu.2018.06.218","journal-title":"World Neurosurg"},{"key":"4038_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.841174","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, Zhang P, Zhao P (2022) Effects of aspirin therapy on bypass efficacy and survival of patients receiving direct cerebral revascularization. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.841174","journal-title":"Front Pharmacol"},{"issue":"1","key":"4038_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-022-00305-0","volume":"8","author":"H Niu","year":"2022","unstructured":"Niu H, Tan C, Jin K, Duan R, Shi G, Wang R (2022) Risk factors for early seizure after revascularization in patients with moyamoya disease. Chin Neurosurg J 8(1):44. https:\/\/doi.org\/10.1186\/s41016-022-00305-0","journal-title":"Chin Neurosurg J"},{"issue":"1","key":"4038_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000504743","volume":"49","author":"Y Qian","year":"2020","unstructured":"Qian Y, Huang B, Hu Z, Wang J, Zhao P, Li X (2020) Analysis of factors related to cerebral infarction after direct bypass surgery in adults with Moyamoya disease. Cerebrovasc Dis 49(1):55\u201361. https:\/\/doi.org\/10.1159\/000504743","journal-title":"Cerebrovasc Dis"},{"key":"4038_CR25","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.12659\/MSM.910252","volume":"24","author":"X Tao","year":"2018","unstructured":"Tao X, Liu Y, Chen J et al (2018) Assessment of single-barrel superficial temporal artery-middle cerebral artery bypass in treatment for adult patients with ischemic-type Moyamoya Disease. Med Sci Monit 24:7469\u20137474. https:\/\/doi.org\/10.12659\/MSM.910252","journal-title":"Med Sci Monit"},{"issue":"10","key":"4038_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1007\/s00415-018-8997-2","volume":"265","author":"M Kraemer","year":"2018","unstructured":"Kraemer M, Sassen J, Karakaya R et al (2018) Moyamoya angiopathy: early postoperative course within 3 months after STA\u2013MCA\u2013bypass surgery in Europe\u2014a retrospective analysis of 64 procedures. J Neurol 265(10):2370\u20132378. https:\/\/doi.org\/10.1007\/s00415-018-8997-2","journal-title":"J Neurol"},{"issue":"5","key":"4038_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/0115672026287201240110092653","volume":"20","author":"D Xu","year":"2023","unstructured":"Xu D, Guo J, Zheng B et al (2023) Risk factors for cerebral hyperperfusion syndrome after combined revascularization in adult patients with Moyamoya Disease. Curr Neurovasc Res 20(5):623\u2013629. https:\/\/doi.org\/10.2174\/0115672026287201240110092653","journal-title":"Curr Neurovasc Res"},{"key":"4038_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1274038","author":"F Gao","year":"2023","unstructured":"Gao F, Cong J, Duan Y (2023) Screening of postoperative cerebral hyperperfusion syndrome in moyamoya disease: a three-dimensional pulsed arterial-spin labeling magnetic resonance imaging approach. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1274038","journal-title":"Front Neurosci"},{"issue":"3","key":"4038_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3171\/2013.11.JNS131027","volume":"120","author":"N Lin","year":"2014","unstructured":"Lin N, Aronson JP, Manjila S, Smith ER, Scott RM (2014) Treatment of Moyamoya disease in the adult population with pial synangiosis: clinical article. J Neurosurg 120(3):612\u2013617. https:\/\/doi.org\/10.3171\/2013.11.JNS131027","journal-title":"J Neurosurg"},{"issue":"4","key":"4038_CR30","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3892\/etm.2018.5850","volume":"15","author":"J Zhao","year":"2018","unstructured":"Zhao J, Liu H, Zou Y, Zhang W, He S (2018) Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with Moyamoya disease: a retrospective study of 76 procedures. Exp Ther Med 15(4):3570\u20133576. https:\/\/doi.org\/10.3892\/etm.2018.5850","journal-title":"Exp Ther Med"},{"key":"4038_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.1047727","author":"D Xu","year":"2022","unstructured":"Xu D, Zheng B, Wu Q (2022) Outcomes after superficial temporal artery\u2013middle cerebral artery anastomosis combined with multiple burr hole surgery and dural inversion synangiosis for moyamoya disease in adults. Front Surg. https:\/\/doi.org\/10.3389\/fsurg.2022.1047727","journal-title":"Front Surg"},{"key":"4038_CR32","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.wneu.2018.07.088","volume":"119","author":"SC Chou","year":"2018","unstructured":"Chou SC, Chen YF, Lee CW et al (2018) Improving indirect revascularization for effective treatment of adult Moyamoya disease: a prospective clinical, cerebral angiographic, and perfusion study. World Neurosurg 119:e180\u2013e191. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.088","journal-title":"World Neurosurg"},{"issue":"3","key":"4038_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/0028-3886.378661","volume":"71","author":"E Liu","year":"2023","unstructured":"Liu E, Jin L, Tao W et al (2023) Analysis of risk factors for epilepsy after combined re-vascularization in adult patients with Moyamoya disease. Neurol India 71(3):471. https:\/\/doi.org\/10.4103\/0028-3886.378661","journal-title":"Neurol India"},{"issue":"5","key":"4038_CR34","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1227\/NEU.0b013e31820c045a","volume":"68","author":"SC Jin","year":"2011","unstructured":"Jin SC, Oh CW, Kwon OK et al (2011) Epilepsy after bypass surgery in adult Moyamoya disease. Neurosurgery 68(5):1227. https:\/\/doi.org\/10.1227\/NEU.0b013e31820c045a","journal-title":"Neurosurgery"},{"issue":"6","key":"4038_CR35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3171\/2014.8.JNS132176","volume":"121","author":"PK Agarwalla","year":"2014","unstructured":"Agarwalla PK, Stapleton CJ, Phillips MT, Walcott BP, Venteicher AS, Ogilvy CS (2014) Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya: clinical article. J Neurosurg 121(6):1394\u20131400. https:\/\/doi.org\/10.3171\/2014.8.JNS132176","journal-title":"J Neurosurg"},{"key":"4038_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1273822","author":"L Lu","year":"2023","unstructured":"Lu L, Huang Y, Han Y (2023) Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1273822","journal-title":"Front Neurol"},{"key":"4038_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1100901","author":"L Li","year":"2023","unstructured":"Li L, Wang A, Wang C (2023) Superficial temporal artery\u2013middle cerebral artery bypass in combination with encephalo-myo-synangiosis in Chinese adult patients with moyamoya disease. Front Surg. https:\/\/doi.org\/10.3389\/fsurg.2023.1100901","journal-title":"Front Surg"},{"key":"4038_CR38","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.wneu.2019.08.182","volume":"132","author":"K Ravina","year":"2019","unstructured":"Ravina K, Kim PE, Rennert RC et al (2019) Lessons learned from the initial experience with pedicled temporoparietal fascial flap for combined revascularization in Moyamoya angiopathy: a case series. World Neurosurg 132:e259\u2013e273. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.182","journal-title":"World Neurosurg"},{"issue":"11","key":"4038_CR39","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1007\/s00415-018-9044-z","volume":"265","author":"A Kahn","year":"2018","unstructured":"Kahn A, Kaur G, Stein L, Tuhrim S, Dhamoon MS (2018) Treatment course and outcomes after revascularization surgery for Moyamoya disease in adults. J Neurol 265(11):2666\u20132671. https:\/\/doi.org\/10.1007\/s00415-018-9044-z","journal-title":"J Neurol"},{"issue":"1","key":"4038_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2019.10.JNS191207","volume":"134","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li S, Fujimura M et al (2019) Hemodynamic analysis of the recipient Parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with Moyamoya disease. J Neurosurg 134(1):17\u201324. https:\/\/doi.org\/10.3171\/2019.10.JNS191207","journal-title":"J Neurosurg"},{"issue":"8","key":"4038_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104846","volume":"29","author":"M Zhang","year":"2020","unstructured":"Zhang M, Tang J, Liu N, Xue Y, Ren X, Fu J (2020) Postoperative functional outcomes and prognostic factors in two types of adult Moyamoya diseases. J Stroke Cerebrovasc Dis 29(8):104846. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104846","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"4038_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-023-00321-8","volume":"9","author":"Z Shi","year":"2023","unstructured":"Shi Z, Wu L, Wang Y, Zhang H, Yang Y, Hang C (2023) Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease. Chin Neurosurg J 9(1):10. https:\/\/doi.org\/10.1186\/s41016-023-00321-8","journal-title":"Chin Neurosurg J"},{"issue":"1","key":"4038_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105413","volume":"30","author":"C Li","year":"2021","unstructured":"Li C, Zhang N, Yu S et al (2021) Individualized perioperative blood pressure management for adult Moyamoya Disease: experience from 186 consecutive procedures. J Stroke Cerebrovasc Dis 30(1):105413. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105413","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"4038_CR44","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3171\/2014.7.JNS132434","volume":"121","author":"H Jiang","year":"2014","unstructured":"Jiang H, Ni W, Xu B et al (2014) Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass: clinical article. J Neurosurg 121(5):1048\u20131055. https:\/\/doi.org\/10.3171\/2014.7.JNS132434","journal-title":"J Neurosurg"},{"issue":"5","key":"4038_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.wneu.2015.01.016","volume":"83","author":"H Imai","year":"2015","unstructured":"Imai H, Miyawaki S, Ono H, Nakatomi H, Yoshimoto Y, Saito N (2015) The importance of encephalo-myo-synangiosis in surgical revascularization strategies for Moyamoya disease in children and adults. World Neurosurg 83(5):691\u2013699. https:\/\/doi.org\/10.1016\/j.wneu.2015.01.016","journal-title":"World Neurosurg"},{"issue":"11","key":"4038_CR46","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/jcbfm.2012.110","volume":"32","author":"Y Kaku","year":"2012","unstructured":"Kaku Y, Iihara K, Nakajima N et al (2012) Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with Moyamoya Disease. J Cereb Blood Flow Metab 32(11):2066\u20132075. https:\/\/doi.org\/10.1038\/jcbfm.2012.110","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"4038_CR47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","volume":"47","author":"H Uchino","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K (2016) Edaravone reduces hyperperfusion-related neurological deficits in adult Moyamoya disease. Stroke 47(7):1930\u20131932. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013304","journal-title":"Stroke"},{"issue":"6","key":"4038_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1159\/000524240","volume":"51","author":"Y Bao","year":"2022","unstructured":"Bao Y, Yu F, Wei L et al (2022) Association between cognitive decline and altered cerebral perfusion in adults with Moyamoya Disease after revascularization. Cerebrovasc Dis 51(6):764\u2013773. https:\/\/doi.org\/10.1159\/000524240","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"4038_CR49","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1227\/NEU.0b013e31820c045a","volume":"68","author":"SC Jin","year":"2011","unstructured":"Jin SC, Oh CW, Kwon OK et al (2011) Epilepsy after bypass surgery in adult moyamoya disease. Neurosurgery 68(5):1227\u20131232. https:\/\/doi.org\/10.1227\/NEU.0b013e31820c045a","journal-title":"Neurosurgery"},{"key":"4038_CR50","unstructured":"OCEBM Levels of Evidence. Accessed October 24 (2024) https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence"},{"issue":"2","key":"4038_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.surneu.2007.07.077","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Shimizu H, Mugikura S, Tominaga T (2009) Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71(2):223\u2013227. https:\/\/doi.org\/10.1016\/j.surneu.2007.07.077","journal-title":"Surg Neurol"},{"key":"4038_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.wneu.2016.04.083","volume":"92","author":"H Sun","year":"2016","unstructured":"Sun H, Wilson C, Ozpinar A et al (2016) Perioperative complications and long-term outcomes after bypasses in adults with Moyamoya disease: a systematic review and meta-analysis. World Neurosurg 92:179\u2013188. https:\/\/doi.org\/10.1016\/j.wneu.2016.04.083","journal-title":"World Neurosurg"},{"issue":"6","key":"4038_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3171\/2018.6.PEDS18151","volume":"22","author":"SJ Yeh","year":"2018","unstructured":"Yeh SJ, Tang SC, Tsai LK et al (2018) Greater ultrasonographic changes in pediatric moyamoya patients compared with adults after indirect revascularization surgeries. J Neurosurg Pediatr 22(6):663\u2013671. https:\/\/doi.org\/10.3171\/2018.6.PEDS18151","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"4038_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1227\/NEU.0000000000001201","volume":"80","author":"H Uchino","year":"2017","unstructured":"Uchino H, Kim JH, Fujima N et al (2017) Synergistic interactions between direct and indirect bypasses in combined procedures: the significance of indirect bypasses in Moyamoya disease. Neurosurgery 80(2):201\u2013209. https:\/\/doi.org\/10.1227\/NEU.0000000000001201","journal-title":"Neurosurgery"},{"issue":"1","key":"4038_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00062-018-0748-3","volume":"30","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Lu J, Zhang Q et al (2020) Time course of neoangiogenesis after indirect bypass surgery for Moyamoya disease: comparison of Short-term and Long-term Follow-up angiography. Clin Neuroradiol 30(1):91\u201399. https:\/\/doi.org\/10.1007\/s00062-018-0748-3","journal-title":"Clin Neuroradiol"},{"issue":"2","key":"4038_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/2014.10.JNS132369","volume":"122","author":"Xju Liu","year":"2015","unstructured":"Liu Xju, Zhang D, Wang S et al (2015) Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg 122(2):392\u2013399. https:\/\/doi.org\/10.3171\/2014.10.JNS132369","journal-title":"J Neurosurg"},{"issue":"1","key":"4038_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-024-02285-4","volume":"47","author":"S Batista","year":"2024","unstructured":"Batista S, Koester S, Bishay AE et al (2024) Complications associated with combined direct and indirect bypass in Moyamoya Disease: a meta-analysis. Neurosurg Rev 47(1):58. https:\/\/doi.org\/10.1007\/s10143-024-02285-4","journal-title":"Neurosurg Rev"},{"issue":"5","key":"4038_CR58","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s10143-020-01459-0","volume":"44","author":"Y Araki","year":"2021","unstructured":"Araki Y, Yokoyama K, Uda K et al (2021) Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis. Neurosurg Rev 44(5):2785\u20132795. https:\/\/doi.org\/10.1007\/s10143-020-01459-0","journal-title":"Neurosurg Rev"},{"key":"4038_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.wneu.2023.01.034","volume":"173","author":"SD Pettersson","year":"2023","unstructured":"Pettersson SD, Olofsson HKL, Ali S, Szarek D, Mi\u0119kisiak G, Ogilvy CS (2023) Risk factors for ischemic stroke after revascularization surgery in patients with Moyamoya disease: an age-stratified comparative meta-analysis. World Neurosurg 173:146-157e14. https:\/\/doi.org\/10.1016\/j.wneu.2023.01.034","journal-title":"World Neurosurg"},{"key":"4038_CR60","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S et al (2021) <article-title update=\"added\">2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke. https:\/\/doi.org\/10.1161\/STR.0000000000000375","DOI":"10.1161\/STR.0000000000000375"},{"key":"4038_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.wneu.2019.11.065","volume":"135","author":"J Yu","year":"2020","unstructured":"Yu J, Zhang J, Li J, Zhang J, Chen J (2020) Cerebral hyperperfusion syndrome after revascularization surgery in patients with Moyamoya disease: systematic review and meta-analysis. World Neurosurg 135:357-366.e4. https:\/\/doi.org\/10.1016\/j.wneu.2019.11.065","journal-title":"World Neurosurg"},{"issue":"8","key":"4038_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005929","volume":"50","author":"K Kaneko","year":"2025","unstructured":"Kaneko K, Maekawa Y, Yamaguchi K et al (2025) The differences of cerebral hyperperfusion in patients with Moyamoya disease and atherosclerotic occlusive cerebrovascular disease evaluated by 99mTc-ECD SPECT one day after revascularization surgery. Clin Nucl Med 50(8):e461. https:\/\/doi.org\/10.1097\/RLU.0000000000005929","journal-title":"Clin Nucl Med"},{"issue":"2","key":"4038_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y et al (2014) Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16(2):65\u201372. https:\/\/doi.org\/10.5853\/jos.2014.16.2.65","journal-title":"J Stroke"},{"issue":"6","key":"4038_CR64","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1227\/01.NEU.0000369606.00861.91","volume":"66","author":"S Kuroda","year":"2010","unstructured":"Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y (2010) Novel bypass surgery for Moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery 66(6):1093. https:\/\/doi.org\/10.1227\/01.NEU.0000369606.00861.91","journal-title":"Neurosurgery"},{"key":"4038_CR65","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1016\/j.wneu.2018.07.258","volume":"119","author":"T Ishikawa","year":"2018","unstructured":"Ishikawa T, Yamaguchi K, Kawashima A et al (2018) Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with Moyamoya disease. World Neurosurg 119:e750\u2013e756. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.258","journal-title":"World Neurosurg"},{"key":"4038_CR66","doi-asserted-by":"publisher","unstructured":"Lai PMR, Beazer M, Frerichs KU, Patel NJ, Aziz-Sultan MA, Du R (2024) Association Between Moyamoya Revascularization Surgery and Neurologic Events During Pregnancy: Systematic Review. Neurosurgery. Published online October 2. https:\/\/doi.org\/10.1227\/neu.0000000000003184","DOI":"10.1227\/neu.0000000000003184"},{"issue":"42","key":"4038_CR67","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.2174\/1381612823666171027125408","volume":"23","author":"B Miziak","year":"2017","unstructured":"Miziak B, Borowicz-Reutt K, Rola R, Blaszczyk B, Czuczwar M, Czuczwar SJ (2017) The prophylactic use of antiepileptic drugs in patients scheduled for neurosurgery. Curr Pharm Des 23(42):6411\u20136427. https:\/\/doi.org\/10.2174\/1381612823666171027125408","journal-title":"Curr Pharm Des"},{"issue":"1","key":"4038_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03563.x","volume":"54","author":"KL Fuller","year":"2013","unstructured":"Fuller KL, Wang YY, Cook MJ, Murphy MA, D\u2019Souza WJ (2013) Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 54(1):45\u201357. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03563.x","journal-title":"Epilepsia"},{"issue":"1","key":"4038_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1227\/neu.0000000000002164","volume":"92","author":"M Rahman","year":"2023","unstructured":"Rahman M, Eisenschenk S, Melnick K et al (2023) Duration of prophylactic levetiracetam after surgery for brain tumor: a prospective randomized trial. Neurosurgery 92(1):68. https:\/\/doi.org\/10.1227\/neu.0000000000002164","journal-title":"Neurosurgery"},{"issue":"6","key":"4038_CR70","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3171\/2018.4.JNS1891","volume":"130","author":"CH Lee","year":"2019","unstructured":"Lee CH, Koo HW, Han SR, Choi CY, Sohn MJ, Lee CH (2019) Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis. J Neurosurg 130(6):2063\u20132070. https:\/\/doi.org\/10.3171\/2018.4.JNS1891","journal-title":"J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-04038-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:03:29Z","timestamp":1768651409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-04038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-04038-3","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review utilized published anonymized data and did not require institutional review board approval. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable. This study is based on previously published data and does not include any individual-level data requiring consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}